Open label randomized trial of treatment by perospirone and aripiprazole for schizophrenia patients considering the drug susceptibility gene.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Aripiprazole (Primary) ; Perospirone (Primary)
- Indications Schizophrenia
- Focus Pharmacogenomic; Therapeutic Use
- 01 Sep 2015 Results presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
- 09 Oct 2013 Results presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
- 01 Jan 2013 Results published in Progress in Neuro-Psychopharmacology and Biological Psychiatry.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History